RESMED INC (RMD) Debt-to-equity % [USD] 2015 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Resmed Inc quarterly Debt-to-equity history and growth rate from 2015 to 2024.
  • Resmed Inc Debt-to-equity for the quarter ending March 31, 2024 was 55.6 %, a 12.6% decline year-over-year.
Debt-to-equity, Quarterly (% [USD])
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 55.6 -8.03 -12.6% Mar 31, 2024
Q4 2023 61.4 +3.18 +5.46% Dec 31, 2023
Q3 2023 67.5 +16.8 +33.2% Sep 30, 2023
Q2 2023 66.2 +14.3 +27.5% Jun 30, 2023
Q1 2023 63.6 +8.79 +16% Mar 31, 2023
Q4 2022 58.3 -1.34 -2.25% Dec 31, 2022
Q3 2022 50.7 -11.4 -18.4% Sep 30, 2022
Q2 2022 51.9 -14.2 -21.5% Jun 30, 2022
Q1 2022 54.8 -16.1 -22.7% Mar 31, 2022
Q4 2021 59.6 -18.1 -23.3% Dec 31, 2021
Q3 2021 62.1 -24.4 -28.2% Sep 30, 2021
Q2 2021 66.2 -26.7 -28.8% Jun 30, 2021
Q1 2021 70.9 -25.9 -26.8% Mar 31, 2021
Q4 2020 77.6 -19.7 -20.3% Dec 31, 2020
Q3 2020 86.5 -12.1 -12.3% Sep 30, 2020
Q2 2020 92.9 +2.5 +2.77% Jun 30, 2020
Q1 2020 96.8 +19.2 +24.8% Mar 31, 2020
Q4 2019 97.4 +27.9 +40.2% Dec 31, 2019
Q3 2019 98.6 +34.2 +53% Sep 30, 2019
Q2 2019 90.4 +23.8 +35.7% Jun 30, 2019
Q1 2019 77.5 +3.91 +5.31% Mar 31, 2019
Q4 2018 69.4 -7.42 -9.65% Dec 31, 2018
Q3 2018 64.4 -16.5 -20.4% Sep 30, 2018
Q2 2018 66.6 -18.9 -22.1% Jun 30, 2018
Q1 2018 73.6 -15.9 -17.7% Mar 31, 2018
Q4 2017 76.9 -3.34 -4.16% Dec 31, 2017
Q3 2017 80.9 +11.9 +17.3% Sep 30, 2017
Q2 2017 85.5 +25 +41.4% Jun 30, 2017
Q1 2017 89.5 +43.5 +94.4% Mar 31, 2017
Q4 2016 80.2 +33.6 +72.2% Dec 31, 2016
Q3 2016 69 +22.5 +48.4% Sep 30, 2016
Q2 2016 60.5 +17.6 +41% Jun 30, 2016
Q1 2016 46 +4.12 +9.83% Mar 31, 2016
Q4 2015 46.6 Dec 31, 2015
Q3 2015 46.5 Sep 30, 2015
Q2 2015 42.9 Jun 30, 2015
Q1 2015 41.9 Mar 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.